| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate |
2000-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6683402f1ad55cf5b4bec863ff311a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4ddab81d7a8646125cd26082ba31c92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1acf90e22851c1649788b25d5a7d9b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f9183a040228f9d08b36c982bba730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013ce815f166d8d39a0c2773a9208843 |
| publicationDate |
2001-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2803308-A1 |
| titleOfInvention |
TH1 TYPE-SPECIFIC CD4 T-LYMPHOCYTE LINES AND METHOD FOR THEIR EX VIVO INDUCTION |
| abstract |
A line of specific CD4 T lymphocytes of the TH1 type, inducing an effective CD8 response against an infection caused by an infectious agent, is obtained by taking a biological sample containing T lymphocytes from a donor; isolating CD4+ T cells from this sample; concurrently obtaining dendritic cells isolated from the same sample or from another sample from the same donor; subjecting the CD4+ T lymphocytes previously isolated to an in vitro immunization with a peptide of a protein of the infectious agent exhibiting at least one T epitope, in the presence of the dendritic cells obtained previously; carrying out at least one restimulation, under the same conditions as the immunization, with possible replacement of the dendritic cells by B cells from the same donor. |
| priorityDate |
1999-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |